Sanofi Genzyme distributes contributions to non-profit organizations, hospitals, research institutions, disease organizations, and medical education programs that target efforts in our areas of disease and therapeutic focus:
- Atopic Dermatitis
- Multiple Sclerosis
- Rare Genetic Diseases
- Rheumatoid Arthritis
- Thyroid Cancer
Sanofi Genzyme also provides Community Relations funding to support non-profit organizations focused on science education, health/access to health care, and unmet community needs, specifically in and around the areas in the U.S. where Sanofi Genzyme has a business presence. Community Relations contributions are only available to certified non-profit organizations, and for specific programs and initiatives, not for general operating expenses or capital campaigns.
Sanofi Genzyme accepts contribution requests through our online application; please do not submit proposals on paper or through other means. Once you complete the online process, you'll be notified by email upon our receipt of your application. During our review we may also contact you with follow-up questions.Applications can be submitted online at any time, all year round. Please be sure to apply well in advance of your funding needs because the application review process can take from 8 to 16 weeks. Community Relations contributions are only reviewed quarterly; those applications received by the quarterly deadline dates (February 15, May 15, August 15, November 15) will be considered during the subsequent review meeting, approximately one month after the deadline. Review meetings for other types of contributions are held on an as-needed basis. We are unable to fund any programs after the event date.
In all cases, Sanofi Genzyme notifies applicants of our decision by email. We receive many qualified and deserving applications and regret that we cannot fund all of them. All applications receive a fair review, and we encourage organizations to reapply for future programs and initiatives.
We are committed to the transparency of our interactions with health care professionals and institutions consistent with applicable laws in countries in which Sanofi Genzyme has affiliates. Information relating to payments or other transfers of value to these recipients will be collected and reported as required under U.S. federal and state laws and regulations, including the “Sunshine” regulations.